The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study

    1. Maria Krutikov
    2. Oliver Stirrup
    3. Hadjer Nacer-Laidi
    4. Borscha Azmi
    5. Chris Fuller
    6. Gokhan Tut
    7. Tom Palmer
    8. Madhumita Shrotri
    9. Aidan Irwin-Singer
    10. Verity Baynton
    11. Andrew Hayward
    12. Paul Moss
    13. Andrew Copas
    14. Laura Shallcross

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    6 evaluationsAppears in 2 listsLatest version Latest activity

  2. Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassay

    1. Joseph M. Johnson
    2. Syrena C. Fernandes
    3. Danica L. Wuelfing
    4. Aaron R. Baillargeon
    5. Evan L. MacLure
    6. Soyoon Hwang
    7. Andrew J. Ball
    8. Narayanaiah Cheedarla
    9. Hans P. Verkerke
    10. Sindhu Potlapalli
    11. Kaleb Benjamin McLendon
    12. Andrew Neish
    13. William O’Sick
    14. John D. Roback
    15. David H. Wilson
    16. Dawn Mattoon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1

    1. Boris Simonetti
    2. James L. Daly
    3. Lorena Simón-Gracia
    4. Katja Klein
    5. Saroja Weeratunga
    6. Carlos Antón-Plágaro
    7. Allan Tobi
    8. Lorna Hodgson
    9. Philip A. Lewis
    10. Kate J. Heesom
    11. Deborah K. Shoemark
    12. Andrew D. Davidson
    13. Brett M. Collins
    14. Tambet Teesalu
    15. Yohei Yamauchi
    16. Peter J. Cullen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Sialic acid and fucose residues on the SARS-CoV-2 receptor binding domain modulate IgG reactivity

    1. Ebba Samuelsson
    2. Ekaterina Mirgorodskaya
    3. Kristina Nyström
    4. Malin Bäckström
    5. Jan-Åke Liljeqvist
    6. Rickard Nordén

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan

    1. Wajiha Rizwan
    2. Ahmad Uzair Qureshi
    3. Muhammad Nasir Rana
    4. Mubeen Nazar Duggal
    5. Muhammad Sohaib
    6. Masood Sadiq

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Microbial GWAS studies revealing combinations of Omicron RBD mutations existed and may contribute to antibody evasion and ACE2 binding

    1. Xumin Ou
    2. Zhishuang Yang
    3. Dekang Zhu
    4. Sai Mao
    5. Mingshu Wang
    6. Renyong Jia
    7. Shun Chen
    8. Mafeng Liu
    9. Qiao Yang
    10. Ying Wu
    11. Xinxin Zhao
    12. Shaqiu Zhang
    13. Juan Huang
    14. Qun Gao
    15. Yunya Liu
    16. Ling Zhang
    17. Maikel Peopplenbosch
    18. Qiuwei Pan
    19. Anchun Cheng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Outbreak.info Research Library: a standardized, searchable platform to discover and explore COVID-19 resources

    1. Ginger Tsueng
    2. Julia L. Mullen
    3. Manar Alkuzweny
    4. Marco Cano
    5. Benjamin Rush
    6. Emily Haag
    7. Jason Lin
    8. Dylan J. Welzel
    9. Xinghua Zhou
    10. Zhongchao Qian
    11. Alaa Abdel Latif
    12. Emory Hufbauer
    13. Mark Zeller
    14. Kristian G. Andersen
    15. Chunlei Wu
    16. Andrew I. Su
    17. Karthik Gangavarapu
    18. Laura D. Hughes

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients

    1. Maria Teresa Lupo-Stanghellini
    2. Serena Di Cosimo
    3. Massimo Costantini
    4. Sara Monti
    5. Renato Mantegazza
    6. Alberto Mantovani
    7. Carlo Salvarani
    8. Pier Luigi Zinzani
    9. Matilde Inglese
    10. Fabio Ciceri
    11. Giovanni Apolone
    12. Gennaro Ciliberto
    13. Fausto Baldanti
    14. Aldo Morrone
    15. Valentina Sinno
    16. Franco Locatelli
    17. Stefania Notari
    18. Elena Turola
    19. Diana Giannarelli
    20. Nicola Silvestris

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19

    1. Angela Y. Chang
    2. Peter Aaby
    3. Michael S. Avidan
    4. Christine S. Benn
    5. Stefano M. Bertozzi
    6. Lawrence Blatt
    7. Konstantin Chumakov
    8. Shabaana A. Khader
    9. Shyam Kottilil
    10. Madhav Nekkar
    11. Mihai G. Netea
    12. Annie Sparrow
    13. Dean T. Jamison

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants

    1. Yohei Seki
    2. Yasuo Yoshihara
    3. Kiyoko Nojima
    4. Haruka Momose
    5. Shuetsu Fukushi
    6. Saya Moriyama
    7. Ayumi Wagatsuma
    8. Narumi Numata
    9. Kyohei Sasaki
    10. Tomoyo Kuzuoka
    11. Yoshiyuki Yato
    12. Yoshimasa Takahashi
    13. Ken Maeda
    14. Tadaki Suzuki
    15. Takuo Mizukami
    16. Isao Hamaguchi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 683 of 2361 Older